SCHEMBL5596775

SCHEMBL5596775

[CH2]COCCCN(CC)CC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
KMT2A Q03164 1/20 0.43
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAOB P27338 2/20 0.36
SIGMAR1 Q99720 1/20 0.35
SLC2A1 P11166 1/20 0.34
BCHE P06276 2/20 0.33
HRH3 Q9Y5N1 2/20 0.33
CHRM2 P08172 2/20 0.33
CHRM4 P08173 2/20 0.33
CHRM1 P11229 2/20 0.33
CHRM3 P20309 2/20 0.33
HTR1A P08908 1/20 0.33
CHRM5 P08912 1/20 0.33
ADRA2C P18825 1/20 0.33
HRH2 P25021 1/20 0.33
HTR1D P28221 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1643971 0.85 MEN1 (0.58) MEN1POLBKMT2AKDM4EALDH1A1
SCHEMBL1537337 0.85 MEN1 (0.44) MEN1POLBKMT2AKDM4EALDH1A1
SCHEMBL5597015 0.84 MEN1 (0.42) MEN1POLBKMT2AKDM4EALDH1A1
SCHEMBL5444857 0.82 MEN1 (0.43) MEN1POLBKMT2AKDM4EALDH1A1
SCHEMBL6124099 0.82 BCHE (0.43) MEN1POLBKMT2AKDM4EALDH1A1
SCHEMBL25634922 0.82 MEN1 (0.43) MEN1POLBKMT2AKDM4EALDH1A1
SCHEMBL16353954 0.81 MEN1 (0.54) MEN1POLBKMT2AKDM4EALDH1A1
SCHEMBL16353741 0.81 MEN1 (0.54) MEN1POLBKMT2AKDM4EALDH1A1
SCHEMBL15833525 0.80 MEN1 (0.41) MEN1POLBKMT2AKDM4EALDH1A1
SCHEMBL15003861 0.80 MEN1 (0.52) MEN1POLBKMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1829876-A1 NITROGENEOUS TRICYCLIC COMPOUND Asahi Kasei Pharma Corporation (JP) 2007-09-05 EP disclosed
US-20060247266-A1 Nitrogen-containing tricyclic compounds ASAHI KASEI PHARMA CORPORATION (JP) 2006-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247266-A1 Nitrogen-containing tricyclic compounds MYO1B, CHRM1, MYL12A MEN1 2341/4885POLB 2903/4885KMT2A 2386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.